|
Volumn 7, Issue 6, 2001, Pages 513-517
|
Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B ANTIBODY;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
LAMIVUDINE;
VIRUS DNA;
ADULT;
ALLOGRAFT;
ARTICLE;
CHRONIC DISEASE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE PREDISPOSITION;
DISEASE TRANSMISSION;
DOSE RESPONSE;
DRUG EFFICACY;
FOLLOW UP;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOPROPHYLAXIS;
LIVER BIOPSY;
LIVER TRANSPLANTATION;
ORGAN DONOR;
PATIENT CARE;
PRIORITY JOURNAL;
RECIPIENT;
SAFETY;
SEROLOGY;
UNITED STATES;
|
EID: 0034977879
PISSN: 15276465
EISSN: None
Source Type: Journal
DOI: 10.1053/jlts.2001.23911 Document Type: Article |
Times cited : (98)
|
References (28)
|